StockData
Replimune Group, Inc. logo

Replimune Group, Inc. (REPL) stock

REPLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q/A on Nov 6, 2026Score 1/30
$19.69−1.72 (-8.03%)

Close on Nov 17, 2026Market cap $1.87BP/E –Yield –

Replimune price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Replimune's price to book ratio was 17.3× on Nov 11, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 0.9× to 17.3×, with a median of 2.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.3×+14.4
2025Dec 31, 20252.9×+0.7
2024Dec 31, 20242.2×+1.1
2023Dec 29, 20231.1×−2.5
2022Dec 30, 20223.5×+0.7
2021Dec 31, 20212.8×−3.1
2020Dec 31, 20205.9×+2.1
2019Dec 31, 20193.8×+1.7
2018Dec 31, 20182.1×–

More Replimune figures

See a number that looks wrong?